Long Term Outcome of Patients Treated on Clinical Trials of Immunomodulatory Agents for the Treatment of AL Amyloidosis: A Pooled Analysis
American Journal of Hematology - United States
doi 10.1002/ajh.25497
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 3, 2019
Authors
Publisher
Wiley